Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas-Reference-Cited by-同舟云学术

Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomas

Published:2010-11 Issue: Volume:36 Page:S87-S94
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Fazio Nicola,Cinieri Saverio,Lorizzo Katia,Squadroni Michela,Orlando Laura,Spada Francesca,Maiello Evaristo,Bodei Lisa,Paganelli Giovanni,Delle Fave Gianfranco,de Braud Filippo

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference108 articles.

1. A 5-decade analysis of 13715 carcinoid tumors;Modlin;Cancer,2003

2. Gastroenteropancreatic neuroendocrine tumours;Modlin;Lancet Oncol,2008

3. One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

4. The diagnosis and medical management of advanced endocrine tumors;Kaltsas;Endocr Rev,2004

5. Histological Typing of Endocrine Tumours;Solcia,2000

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial;Pharmaceutics;2022-09-22

2. Small Bowel Neuroendocrine Tumors: Focus on Pathologic Aspects and Controversial Surgical Issues;Current Surgery Reports;2022-08-28

3. Optimization of the tumour response threshold in advanced gastroenteropancreatic neuroendocrine carcinomas treated with cisplatin/etoposide combined chemotherapy;European Journal of Radiology;2022-02

4. Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies;Translational Oncology;2022-01

5. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers part 2: Neuroendocrine tumours, hepatocellular carcinoma, and gastro-intestinal stromal tumours;Pharmacology & Therapeutics;2018-01